Acute CHF: GDMT Up-titration After Hospitalization for Acute HF (STRONG-HF Trial)
Study: STRONG-HF trial examined rapid up-titration of heart failure medications (GDMT) after hospitalization. Goal: Reach optimal GDMT doses within 2 weeks after discharge. Findings: Over 90% of patie...
19 Jan 20245min
LIPIDS: Treat to Target or with High Intensity (LODESTAR Trial)
Key Points from "Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR": The study compares two strategies for managing LDL cholesterol in coronary artery disease (CAD): Treat-to-t...
15 Jan 20244min
Tricuspid Regurgitation: TEER for severe TR (Triluminate Pivotal Trial)
Key Points of the Study: T-TEER with the TriClip device significantly improved health status in patients with severe tricuspid regurgitation (TR) compared to medical therapy alone. This improvement wa...
12 Jan 20243min
PAD: PROMISE II Trial: Deep-Vein Arterialization Shows Promise for No-Option CLTI Patients.
Key Points from PROMISE 2 Trial: • Problem: 20% of CLTI patients have no revascularization options, leading to amputations. • Solution: Transcatheter arterialization of deep veins creates an artery-to...
8 Jan 20242min
Degenerative MR: Two Choices now for Mitral Transcatheter Repair (TEER): Clasp IID Trial
Key Points from this trial: The CLASP IID trial, the first randomized controlled trial comparing the PASCAL system and the MitraClip system in prohibitive-risk patients with significant symptomatic d...
5 Jan 20243min
Sinus Node Disease: DANPACE II trial: Study Debunks Pacing Myth: Minimizing Pacing Doesn't Curb A-Fib
Key points of the DANPACE II study on atrial pacing and atrial fibrillation in sinus node dysfunction: 1. Minimizing atrial pacing in pacemakers doesn't prevent atrial fibrillation (AF): • 46% of pati...
1 Jan 20243min
Major Trends in Cardiology from 2023
Major Trends: Independent Medical Board: Cardiologists seek a new board separate from the ABIM due to concerns with MOC requirements. Scope of Practice Debates: Tensions arise over advanced nurse p...
31 Des 20234min
CAD: Coronary Artery Disease Updates in 2023
Key Points of Coronary Artery Disease Studies in 2023: • ORBITA-2: Confirmed PCI's role in relieving angina symptoms for stable patients. • SELECT: Semaglutide (Ozempic) reduced cardiovascular events ...
25 Des 20236min
